Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future

Author： Cavaliere Robert   Newton Herbert  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.6, 2006-04, pp. : 749-765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and future directions for Phase II trials in high-grade glioma

By Alexander Brian M   Lee Eudocia Q   Reardon David A   Wen Patrick Y  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. : 369-387

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for high-grade osteosarcoma

By Hattinger Claudia Maria   Pasello Michela   Ferrari Stefano   Picci Piero   Serra Massimo  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 615-634

Informa Healthcare

Access to resources Recommend Favorite

Targeting ErbB Receptors in High-Grade Glioma

By  

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2468-2487

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Effect of Immunotherapy and Chemotherapy in Cancers: Perspective in High Grade Glioma Treatment

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 8, 2006-01 ,pp. : 513-523

Bentham Science Publishers

Access to resources Recommend Favorite

Carmustine-impregnated wafers and their impact in the management of high-grade glioma

By La Rocca Renato V   Rezazadeh Arash  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1325-1332

Informa Healthcare

Access to resources Recommend Favorite